drugset / Trial / NCT02777242
Safety of Subcutaneous Testosterone Enanthate in Adult Male Hypogonadism
NaSingle-groupOpen-labelTreatment
Summary
Evaluation of the safety and tolerability of testosterone enanthate (TE) following a single dose via QuickShot® Testosterone (QST) when administered by intended users in a usability study.
Timeline
- Start
- 2016-06
- Primary completion
- 2016-08
- Completion
- 2016-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Testosterone Enanthate | Small molecule | 50 mg | Subcutaneous |
| Subject | Testosterone Enanthate | Small molecule | 75 mg | Subcutaneous |
| Subject | Testosterone Enanthate | Small molecule | 100 mg | Subcutaneous |